Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-24
1999-07-20
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142365, 514252, 514305, 514326, 514331, 514341, 5143731, 5143771, 514397, 514399, 514406, 540603, 544110, 544140, 544371, 546133, 546211, 5462754, 5483435, 5483731, 5483771, A61K 3142, A61K 31415, C07D26318, C07D41303
Patent
active
059256613
ABSTRACT:
The invention relates to compounds of the formula: ##STR1## Compounds of the above formula have a great affinity for the neurotensin receptors.
REFERENCES:
patent: 5420141 (1995-05-01), Boigegrain et al.
Data Base Crossfire, BRN=509860, & Justus Liebigs AA. Chem., vol. 120, 1861 p. 126.
Database Crossfire, BRN=1841460, & J. Chem. Soc., p. 4060 1964.
Database Crossfire, BRN=3297648 & Andre `Dissertation`, 1909, Bonn p. 27.
Database Crossfire, BRN=3257569, & Auden `Dissertation`, 1897, Tuebingen, p. 17.
Database Crossfire, BRN=3312692, & Chem. Ber., vol. 62, 1929, p. 2566.
Database Cross Fire, BRN=1818200, & Helv. Chim. Acta, pp. 793-797, vol. 43, 1960.
Database Crossfire, BRN=910233, & Chem. Ber., vol. 21, 1988, p. 3409
Database Crossfire, BRN=1818353, & Indian J. Chem., vol. 1, 1963, pp. 247-249.
Database Crossfire, BRN=1818417, & US-A-4 105 766 (Sterling Drug) (1978).
Database Cross Fire, BRN=1818415, & US-A-4 105 766 (Sterling Drug) (1978).
Database Crossfire, BRN=1819156, & Chem Ber., vol. 96, 1963, pp. 184-187.
Database Crossfire, BRN=3274365, & Chem. Ber., vol. 18, 1885, p. 3175.
Database Crossfire, BRN=3285701, & Chem. Ber., vol. 21, 1888, p. 3223.
Database Crossfire, BRN=3293381, & ZH Obshch, Khim., vol. 4, 1934, pp. 728-731.
Database Crossfire, BRN=3330098, & J Amer. Chem. Soc., vol. 45, 1923, p. 1491.
Database Crossfire, BRN=3285692, & Recl. Trav. Chim. Pays-Bas, vol. 24, 1905, p. 206.
Database Crossfire, BRN=387378, & Chem. Ber., vol. 86, 1953, pp. 073-1075.
Database Crossfire, BRN=1818729, & Chem. Ber., vol. 85, 1952, pp. 760-773.
Database Crossfire, BRN=1841461, & J. Amer. Chem. Soc., vol. 66, 1944, pp. 1851-1854.
Database Crossfire, BRN=514779, & Helv. Chim. Acta, vol. 17, 1934, pp. 1416-1417.
Database Crossfire, BRN=776989, & Am. Chem. J., vol. 37, 1907, p. 365.
Database Crossfire, BRN=3274303, & Chem. Ber., vol. 18, 1885, p. 2193.
Database Crossfire, BRN=3283626, & Chem. Ber., vol. 18, 1882, p. 2193.
Database Crossfire, BRN=1818557, Indian J. Chem., vol. 1, 1963, pp. 247-250.
Gully et al., "Biochemical and Pharmacological Profile of a Patent and Selective Nonpeptide Antagonist of the Neurotensin Receptor",Proc. Natl. Acad. Sci., USA, 90, pp. 65-69 (Jan. 1993).
Boigegrain Robert
Gully Danielle
Jeanjean Francis
Labeeuw Bernard
Molimard Jean-Charles
Oswecki Jane C.
Richter Johann
Sanofi
LandOfFree
Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1322224